Совместимость Диданозин и Делстриго
Страница описания препарата Диданозин
Страница описания препарата Делстриго
Cтепень серьёзности/тяжести
Достоверность
Описание взаимодействия
Источники
Печатные издания
Effect of tenofovir on didanosine absorption in patients with HIV
Annals of Pharmacotherapy /Volume:37 Part:9/Sep Page:1325-8 / 2003 / Pecora Fulco P, Kirian MA
Risk factors for CD4 lymphopenia in patients treated with a tenofovir/didanosine high dose-containing highly active antiretroviral therapy regimen
AIDS /Volume:19 Part:10/Jul Page:1107-8 / 2005 / Lacombe K, Pacanowski J, Meynard JL et al
Acute onset pancreatitis with concomitant use of tenofovir and didanosine
Annals of Pharmacotherapy /Volume:38 Part:10/Oct Page:1660-3 / 2004 / Kirian MA, Higginson RT, Fulco PP
Pancreatic toxic effects associated with co-administration of didanosine and tenofovir in HIV-infected adults
Lancet /Volume:364 Part:9428/Jul Page:65-7 / 2004 / Martinez E, Milinkovic A, de Lazzari E et al
Paradoxical CD4+ T-cell decline in HIV-infected patients with complete virus suppression taking tenofovir and didanosine
AIDS /Volume:19 Part:6/Mar Page:1722-3 / 2005 / Barrios A, Rendon A, Negredo E et al
Fatal lactic acidosis associated with coadministration of didanosine and tenofovir disoproxil fumarate
Pharmacotherapy /Volume:24 Part:8/Aug Page:1089-94 / 2004 / Guo Y, Fung HB
The durability of virological success of tenofovir and didanosine dosed at either 400 or 250mg once daily
HIV Medicine /Volume:6 Part:3/May Page:151-4 / 2005 / Tung MY, Mandalia S, Bower M et al
Renal tubular dysfunction associated with tenofovir therapy: report of 7 cases
Journal of Acquired Immune Deficiency Syndromes /Volume:35 Part:3/Mar Page:269-73 / 2004 / Peyriere H, Reynes J, Rouanet I et al